PNC Financial Services Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-28
| Closed | -$104 | – | 4981 |
|
|
2024
Q3 | $104 | Hold |
28
| – | – | ﹤0.01% | 4721 |
|
|
2024
Q2 | $157 | Buy |
+28
| New | +$157 | ﹤0.01% | 4693 |
|
|
2023
Q4 | – | Sell |
-15
| Closed | -$237 | – | 4792 |
|
|
2023
Q3 | $237 | Sell |
15
-102
| -87% | -$1.61K | ﹤0.01% | 4523 |
|
|
2023
Q2 | $2.28K | Sell |
117
-242
| -67% | -$4.71K | ﹤0.01% | 4344 |
|
|
2023
Q1 | $10.2K | Sell |
359
-267
| -43% | -$7.57K | ﹤0.01% | 3810 |
|
|
2022
Q4 | $18.3K | Buy |
626
+210
| +50% | +$6.14K | ﹤0.01% | 3509 |
|
|
2022
Q3 | $11K | Sell |
416
-380
| -48% | -$10K | ﹤0.01% | 3744 |
|
|
2022
Q2 | $36K | Sell |
796
-81
| -9% | -$3.66K | ﹤0.01% | 3193 |
|
|
2022
Q1 | $44K | Sell |
877
-262
| -23% | -$13.1K | ﹤0.01% | 3184 |
|
|
2021
Q4 | $58K | Sell |
1,139
-5
| -0.4% | -$255 | ﹤0.01% | 3026 |
|
|
2021
Q3 | $63K | Buy |
1,144
+304
| +36% | +$16.7K | ﹤0.01% | 2931 |
|
|
2021
Q2 | $36K | Buy |
840
+54
| +7% | +$2.31K | ﹤0.01% | 3235 |
|
|
2021
Q1 | $33K | Sell |
786
-127
| -14% | -$5.33K | ﹤0.01% | 3201 |
|
|
2020
Q4 | $43K | Buy |
913
+190
| +26% | +$8.95K | ﹤0.01% | 2995 |
|
|
2020
Q3 | $31K | Buy |
723
+205
| +40% | +$8.79K | ﹤0.01% | 3009 |
|
|
2020
Q2 | $25K | Sell |
518
-69
| -12% | -$3.33K | ﹤0.01% | 3116 |
|
|
2020
Q1 | $27K | Sell |
587
-265
| -31% | -$12.2K | ﹤0.01% | 2963 |
|
|
2019
Q4 | $51K | Sell |
852
-20,612
| -96% | -$1.23M | ﹤0.01% | 2888 |
|
|
2019
Q3 | $1.22M | Sell |
21,464
-8,800
| -29% | -$498K | ﹤0.01% | 1176 |
|
|
2019
Q2 | $1.69M | Buy |
30,264
+29,622
| +4,614% | +$1.65M | ﹤0.01% | 1078 |
|
|
2019
Q1 | $32K | Buy |
642
+392
| +157% | +$19.5K | ﹤0.01% | 3188 |
|
|
2018
Q4 | $10K | Sell |
250
-21
| -8% | -$840 | ﹤0.01% | 3556 |
|
|
2018
Q3 | $19K | Hold |
271
| – | – | ﹤0.01% | 3470 |
|
|
2018
Q2 | $21K | Buy |
271
+144
| +113% | +$11.2K | ﹤0.01% | 3430 |
|
|
2018
Q1 | $7K | Sell |
127
-1,154
| -90% | -$63.6K | ﹤0.01% | 3835 |
|
|
2017
Q4 | $68K | Buy |
1,281
+151
| +13% | +$8.02K | ﹤0.01% | 2772 |
|
|
2017
Q3 | $67K | Sell |
1,130
-10,139
| -90% | -$601K | ﹤0.01% | 2760 |
|
|
2017
Q2 | $889K | Buy |
11,269
+82
| +0.7% | +$6.47K | ﹤0.01% | 1333 |
|
|
2017
Q1 | $928K | Sell |
11,187
-17,333
| -61% | -$1.44M | ﹤0.01% | 1328 |
|
|
2016
Q4 | $2.26M | Sell |
28,520
-12,482
| -30% | -$990K | ﹤0.01% | 935 |
|
|
2016
Q3 | $2.87M | Buy |
41,002
+28,424
| +226% | +$1.99M | ﹤0.01% | 832 |
|
|
2016
Q2 | $488K | Buy |
12,578
+349
| +3% | +$13.5K | ﹤0.01% | 1561 |
|
|
2016
Q1 | $494K | Buy |
12,229
+3,178
| +35% | +$128K | ﹤0.01% | 1564 |
|
|
2015
Q4 | $802K | Sell |
9,051
-337
| -4% | -$29.9K | ﹤0.01% | 1303 |
|
|
2015
Q3 | $694K | Buy |
9,388
+302
| +3% | +$22.3K | ﹤0.01% | 1379 |
|
|
2015
Q2 | $735K | Buy |
+9,086
| New | +$735K | ﹤0.01% | 1415 |
|